Abstract
The protooncogenic protein c-Cbl has been shown to act as a multivalent adaptor and a negative regulator of protein tyrosine kinase-mediated signaling. Recent studies have implicated it in the regulation of cell adhesion-related events. We have previously shown that c-Cbl facilitates adhesion and spreading of v-Abl-transformed fibroblasts, and that these effects are dependent on its tyrosine phosphorylation. However, the mechanisms mediating effects of c-Cbl on fibroblast adhesion remain poorly understood. In this study we demonstrate that the tyrosine phosphorylation-dependent effect of c-Cbl on adhesion of v-Abl-transformed fibroblasts is primarily mediated by an increase in fibronectin matrix deposition by these cells. This increase in fibronectin matrix deposition and, hence, in cell adhesion is dependent on cytoskeletal rearrangements induced by RhoA, Rac1 and, possibly, Rap1 activation caused by c-Cbl. The observed activation of these GTPases is mediated by the recruitment of phosphatidylinositol-3′ kinase, CrkL and Vav2 to the C-terminal tyrosine residues of c-Cbl. The results of this study also demonstrate that ubiquitination is essential for the observed effects of c-Cbl on fibronectin matrix production and cell adhesion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- BD:
-
binding domain
- BDM:
-
3-butanedione 2-monoxime
- ECM:
-
extracellular matrix
- EGFP:
-
enhanced green fluorescent protein
- FN:
-
fibronectin
- GEF:
-
guanine nucleotide exchange factor
- GST:
-
glutathione-S-transferase
- HA:
-
hemagglutinin
- mAb:
-
monoclonal antibody
- PBS:
-
phosphate-buffered saline
- PI-3′ kinase:
-
phosphatidylinositol-3′ kinase
- PTK:
-
protein tyrosine kinase.
References
Akamatsu H, Ichihara-Tanaka K, Ozono K, Kamiike W, Matsuda H, Sekiguchi K . 1996 Cancer Res. 56: 4541–4546
Akiyama S . 1996 Hum. Cell 9: 181–186
Altun-Gultekin ZF, Chandriani S, Bougeret C, Ishizaki T, Narumiya S, de Graaf P, Van Bergen en Henegouwen P, Hanafusa H, Wagner JA, Birge RB . 1998 Mol. Cell. Biol. 18: 3044–3058
Andoniou CE, Lill NL, Thien CB, Lupher ML Jr., Ota S, Bowtell DD, Scaife RM, Langdon WY, Band H . 2000 Mol. Cell. Biol. 20: 851–867
Andoniou CE, Thien CB, Langdon WY . 1996 Oncogene 12: 1981–1989
Arai A, Nosaka Y, Kohsaka H, Miyasaka N, Miura O . 1999 Blood 93: 3713–3722
Bokoch GM, Wang Y, Bohl BP, Sells MA, Quilliam LA, Knaus UG . 1996 J. Biol. Chem. 271: 25746–25749
Christopher RA, Kowalczyk AP, McKeown-Longo PJ . 1997 J. Cell. Sci. 110: 569–581
Chrzanowska-Wodnicka M, Burridge K . 1996 J. Cell. Biol. 133: 1403–1415
Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR . 1997 Nature 385: 169–172
Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne D, Nakano T . 1999 J. Biol. Chem. 274: 37385–37390
Feshchenko EA, Langdon WY, Tsygankov AY . 1998 J. Biol. Chem. 273: 8323–8331
Feshchenko EA, Shore SK, Tsygankov AY . 1999 Oncogene 18: 3703–3715
Franke B, Akkerman J-WN, Bos JL . 1997 EMBO J. 16: 252–259
Gotoh T, Hattori S, Nakamura S, Kitayama H, Noda M, Takai Y, Kaibuchi K, Matsui H, Hatase O, Takahashi H, Kurata T, Matsuda M . 1995 Mol. Cell. Biol. 15: 6746–6753
Gotoh T, Niino Y, Tokuda M, Hatase O, Nakamura S, Matsuda M, Hattori S . 1997 J. Biol. Chem. 272: 18602–18607
Henske E, Short M, Jozwiak S, Bovey C, Ramlakhan S, Haines J, Kwiatkowski D . 1995 Ann. Hum. Genet. 59: 25–37
Herzhoff K, Sollberg S, Huerkamp C, Krieg T, Eckes B . 1999 Br. J. Dermatol. 141: 218–223
Ichiba T, Kuraishi Y, Sakai O, Nagata S, Groffen J, Kurata T, Hattori S, Matsuda M . 1997 J. Biol. Chem. 272: 22215–22220
Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S . 2000 Mol. Pharmacol. 57: 976–983
Jascur T, Gilman J, Mustelin T . 1997 J. Biol. Chem. 272: 14483–14488
Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC . 1999 Science 286: 309–312
Katagiri K, Hattori M, Minato N, Irie S, Takatsu K, Kinashi T . 2000 Mol. Cell. Biol. 20: 1956–1969
Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, Ito M, Matsumura F, Inagaki M, Kaibuchi K . 1999 J. Cell. Biol. 147: 1023–1037
Kawata M, Matsui Y, Kondo J, Hishida T, Teranishi Y, Takai Y . 1988 J. Biol. Chem. 263: 18965–18971
Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K . 1996 Science 273: 245–248
Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M . 1989 Cell 56: 77–84
Klein S, Bikfalvi A, Birkenmeier T, Giancotti F, Rifkin D . 1996 J. Biol. Chem. 271: 22583–22590
Kumar C, Ohashi K, NAgata K, Walsh A, Bar-Sagi D, Mizuno K . 1999 Ann. NY Acad. Sci. 886: 122–131
Lamb NJ, Fernandez A, Conti MA, Adelstein R, Glass DB, Welch WJ, Feramisco JR . 1988 J. Cell. Biol. 106: 1955–1971
Lee D, Goldberg A . 1998 Trends Cell. Biol. 8: 397–403
Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y . 1999 Mol. Cell 4: 1029–1040
Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y . 1998 Genes Deve. 12: 3663–3674
Liu YC, Altman A . 1998 Cell. Signal. 10: 377–385
Liu YC, Elly C, Langdon WY, Altman A . 1997 J. Biol. Chem. 272: 168–173
Lupher Jr. ML, Rao N, Eck MJ, Band H . 1999 Immunol. Today 20: 375–382
Magnusson MK, Mosher DF . 1998 Arterioscl., Thromb. Vasc. Biol. 18: 1363–1370
Malcolm K, Elliott C, Exton J . 1996 J. Biol. Chem. 271: 13135–13139
Marengere LE, Mirtsos C, Kozieradzki I, Veillette A, Mak TW, Penninger JM . 1997 J. Immunol. 159: 70–76
McKillop D, Fortune N, Ranatunga K, Geeves M . 1994 J. Muscle Res. Cell. Motil. 15: 309–318
Meng F, Lowell CA . 1998 EMBO J. 17: 4391–4403
Merlo JJ, Romano G, Gordon SS, Feshchenko EA, Peng G, Henderson EE, Tsygankov AY . 1998 Anticancer Res. 18: 2389–2396
Miyake S, Lupher Jr. ML, Druker B, Band H . 1998 Proc. Natl. Acad. Sci. USA 95: 7927–7932
Nobes CD, Hall A . 1995 Cell 81: 53–62
Nobes CD, Hawkins P, Stephens L, Hall A . 1995 J. Cell. Sci. 108: 225–233
Ojaniemi M, Martin SS, Dolfi F, Olefsky JM, Vuori K . 1997 J. Biol. Chem. 272: 3780–3787
Ota S, Hazeki K, Rao N, Lupher Jr. ML, Andoniou CE, Druker B, Band H . 2000 J. Biol. Chem. 275: 414–422
Parizi M, Howard E, Tomasek J . 2000 Exp. Cell. Biol. 254: 210–220
Parker PJ . 1995 Curr. Biol. 5: 577–579
Quilliam LA, Lambert QT, Mickelson-Young LA, Westwick JK, Sparks AB, Kay BK, Jenkins NA, Gilbert DJ, Copeland NG, Der CJ . 1996 J. Biol. Chem. 271: 28772–28776
Rajaraman R, MacSween J, Murdock C . 1983 Exp. Cell. Biol. 51: 9–18
Reedquist KA, Bos JL . 1998 J. Biol. Chem. 273: 4944–4949
Reedquist KA, Ross E, Koop EA, Wolthuis RM, Zwartkruis FJ, van Kooyk Y, Salmon M, Buckley CD, Bos JL . 2000 J. Cell. Biol. 148: 1151–1158
Reid T, Furuyashiki T, Ishizaki T, Watanabe G, Watanabe N, Fujisawa K, Morii N, Madaule P, Narumiya S . 1996 J. Biol. Chem. 271: 13556–13560
Reif K, Nobes CD, Thomas G, Hall A, Cantrell DA . 1996 Curr. Biol. 6: 1445–1455
Ren X, Kiosses W, Schwartz M . 1999 EMBO J. 18: 578–585
Ridley AJ, Hall A . 1992 Cold Spring Harbor Symp. Quant. Biol. 57: 661–671
Ruoslahti E . 1996 Ann. Rev. Cell. Dev. Biol. 12: 697–715
Ruoslahti E . 1999 Adv. Cancer Res. 76: 1–20
Sander E, van Delft S, ten Klooster J, Reid T, van der Kammen R, Michiels F, Collard J . 1998 J. Cell. Biol. 143: 1385–1398
Scaife RM, Langdon WY . 2000 J. Cell. Sci. 113: 215–226
Scardigli R, Soddu S, Falcioni R, Crescenzi M, Cimino L, Sacchi A . 1996 Exp. Cell. Res. 227: 223–229
Schlaepfer DD, Hunter T . 1998 Trends. Cell. Biol. 8: 151–157
Schoenwaelder SM, Burridge K . 1999 Curr. Opin. Cell. Biol. 11: 274–286
Schuebel KE, Movilla N, Rosa JL, Bustelo XR . 1998 EMBO J. 17: 6608–6621
Tanaka M, Gupta R, Mayer BJ . 1995 Mol. Cell. Biol. 15: 6829–6837
Tapon N, Hall A . 1997 Curr. Opin. Cell Biol. 9: 86–92
Thien CB, Langdon WY . 1998 Immunol. Cell. Biol. 76: 473–482
Tsukamoto N, Hattori M, Yang H, Bos JL, Minato N . 1999 J. Biol. Chem. 274: 18463–18469
Tsygankov A, Mahajan S, Fincke J, Bolen J . 1996 J. Biol. Chem. 271: 27130–27137
Tsygankov AY, Broker BM, Emmrich F . 1992 Cell. Immunol. 140: 97–111
Tsygankov AY, Spana C, Rowley RB, Penhallow RC, Burkhardt AL, Bolen JB . 1994 J. Biol. Chem. 269: 7792–7800
Vaheri A, Alitalo K, Hedman K, Keski-Oja J, Kurkinen M, Wartiovaara J . 1978 Ann. N. Y. Acad. Sci. 312: 343–353
Vaheri A, Mosher D . 1978 Biochim. Biophys. Acta 516: 1–25
Volberg T, Geiger B, Citi S, Bershadsky AD . 1994 Cell Motil. Cytoskel. 29: 321–338
Von Willebrand M, Jascur T, Bonnefoy-Berard N, Yano H, Altman A, Matsuda Y, Mustelin T . 1996 Eur. J. Biochem. 235: 828–835
Walsh A, Dhanasekaran M, Bar-Sagi D, Kumar C . 1997 Oncogene 16: 2553–2560
Wang Y, Yeung YG, Stanley ER . 1999 J. Cell. Biochem. 72: 119–134
Waterman H, Levkowitz G, Alroy I, Yarden Y . 1999 J. Biol. Chem. 274: 22151–22154
Wilde C, Genth H, Aktories K, Just I . 2000 J. Biol. Chem. 275: 16478–16483
Wu C, Keivens VM, O'Toole TE, McDonald JA, Ginsberg MH . 1995 Cell 83: 715–724
Zell T, Warden CS, Chan AS, Cook ME, Dell CL, Hunt SW, 3rd, Shimizu Y . 1998 Curr. Biol. 8: 814–822
Zhang Q, Magnusson MK, Mosher DF . 1997 Mol. Biol. Cell 8: 1415–1425
Zhong C, Chrzanowska-Wodnicka M, Brown J, Shaub A, Belkin AM, Burridge K . 1998 J. Cell Biol. 141: 539–551
Acknowledgements
We thank Drs W Langdon, T Mustelin, K Reedquist and Y Yarden for invaluable discussions and providing reagents, Drs J Bos, J Chernoff, J Collard, C Kumar, B Mayer, L Quilliam, and R Schwartz for providing reagents, Drs C Marcinkiewicz, D Mosser, S Niewiarovski, and S Shore for many helpful suggestions, J Faust for helpful assistance with FACS, and G Harvey for excellent editorial help. This work was supported by the National Institutes of Health grant CA78499 (to AY Tsygankov).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Teckchandani, A., Feshchenko, E. & Tsygankov, A. c-Cbl facilitates fibronectin matrix production by v-Abl-transformed NIH3T3 cells via activation of small GTPases. Oncogene 20, 1739–1755 (2001). https://doi.org/10.1038/sj.onc.1204246
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204246
Keywords
This article is cited by
-
Members of the novel UBASH3/STS/TULA family of cellular regulators suppress T‐cell‐driven inflammatory responses in vivo
Immunology & Cell Biology (2014)
-
A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate
Oncogene (2009)
-
Vav2
AfCS-Nature Molecule Pages (2008)
-
c-Cbl-facilitated cytoskeletal effects in v-Abl-transformed fibroblasts are regulated by membrane association of c-Cbl
Oncogene (2007)
-
TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin
Oncogene (2004)